| |
Latest 10 SEC filings (by transaction date) for RARE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 19/24 | Apr 18/24 | Crombez Eric | Direct Ownership | Common Stock | S - Open market or private sale | -142 | $44.10 |
Apr 18/24 | Apr 16/24 | Huizenga Theodore Alan | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -14 | $42.31 |
Mar 12/24 | Mar 11/24 | Kassberg Thomas Richard | Direct Ownership | Common Stock | S - Open market or private sale | -11,509 | $49.93 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -7,500 | $50.88 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -2,145 | $50.85 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -2,550 | $50.89 |
Mar 5/24 | Mar 1/24 | Horn Howard | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 34,200 | |
Mar 5/24 | Mar 1/24 | Horn Howard | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 19,400 | |
Mar 5/24 | Mar 1/24 | Parschauer Karah Herdman | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 31,400 | |
Mar 5/24 | Mar 1/24 | Parschauer Karah Herdman | Direct Ownership | Common Stock | S - Open market or private sale | -3,756 | $53.76 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RARE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 19/24 | Apr 18/24 | Crombez Eric | Direct Ownership | Common Stock | S - Open market or private sale | -142 | $44.10 |
Apr 18/24 | Apr 16/24 | Huizenga Theodore Alan | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -14 | $42.31 |
Mar 12/24 | Mar 11/24 | Kassberg Thomas Richard | Direct Ownership | Common Stock | S - Open market or private sale | -11,509 | $49.93 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -7,500 | $50.88 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -2,145 | $50.85 |
Mar 11/24 | Mar 7/24 | Fust Matthew K | Direct Ownership | Common Stock | S - Open market or private sale | -2,550 | $50.89 |
Mar 5/24 | Mar 1/24 | Horn Howard | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 34,200 | |
Mar 5/24 | Mar 1/24 | Horn Howard | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 19,400 | |
Mar 5/24 | Mar 1/24 | Parschauer Karah Herdman | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 31,400 | |
Mar 5/24 | Mar 1/24 | Parschauer Karah Herdman | Direct Ownership | Common Stock | S - Open market or private sale | -3,756 | $53.76 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |